Encompass Health (EHC) Q2 2025: Occupancy Jumps 210bps, Fueling Capacity Expansion and Guidance Raise
Encompass Health’s Q2 saw a 210 basis point rise in occupancy, driving further investment in new beds and a guidance lift for the year. Management is leaning into demand tailwinds from an aging population and underserved rehabilitation market, with capital allocation focused on organic growth over M&A. Persistent labor and benefits cost inflation, alongside new AI-driven efficiency efforts, shape the operational landscape as EHC expands its network and refines its quality-driven differentiation.
Summary
- Occupancy-Driven Expansion: Rising occupancy rates are prompting accelerated bed additions and new hospital openings.
- Labor and Benefit Pressures: Wage and benefit inflation remain persistent, but contract labor and turnover are stabilizing.
- AI and Quality Initiatives: Technology and best-practice protocols are supporting efficiency gains and clinical differentiation.
Performance Analysis
Encompass Health delivered broad-based discharge growth in Q2, with total discharges up 7.2% and same store growth of 6.7%. Revenue increased by 12%, driven by higher volumes and improved net revenue per discharge, which benefited from lower bad debt expense as prepayment claim reviews normalized. Net revenue per discharge was also supported by a favorable payer mix shift, notably the growth in the VA Community Care Network, which now represents nearly 18% of managed care business and pays at Medicare rates.
On the cost side, salaries and wages per FTE (full-time equivalent) rose 4%, with a 3.4% increase excluding contract labor and bonuses. Contract labor costs declined 15.1% year over year, with contract labor FTEs now at just 2.3% of total FTEs. However, benefits expense per FTE spiked 18%, driven by an uptick in high-dollar medical claims, though management expects this to moderate in the second half. Adjusted free cash flow rose 31.5% to $186 million, supporting both increased capex for capacity expansion and share repurchases.
- Occupancy Surge: Q2 occupancy hit 76.6%, up 210bps YoY, driving prioritization of new bed and hospital projects.
- Benefits Inflation: High-dollar medical claims are the main driver of benefits cost growth, outpacing wage inflation.
- Payer Mix Tailwind: VA Community Care Network growth is lifting managed care pricing and overall revenue quality.
With 56% of beds now private, up from 41% in 2020, EHC is positioned to flex occupancy further as new capacity comes online. The company’s capital allocation remains disciplined, focusing on organic growth and shareholder returns within a favorable leverage profile.
Executive Commentary
"Our discharge growth was, again, broad-based across geographies, payers, and patient type. Our focus remains on successfully treating patients with complex medical conditions... The demand for inpatient rehabilitation services remains considerably underserved and continues to grow as the US population ages."
Mark Tarr, President and Chief Executive Officer
"On the basis of our strong Q2 performance and the tax benefit of additional bonus appreciation resulting from recent legislation, we now expect 2025 adjusted free cash flow of 705 to 795 million... The likely place to go is going to be with more share repurchase activity."
Doug Colvin, Executive Vice President and Chief Financial Officer
Strategic Positioning
1. Capacity Expansion as Primary Growth Lever
EHC is doubling down on organic growth by accelerating bed additions and new hospital openings. The company raised its 2025 capex guidance twice this year, now adding $25 million for a new Tennessee hospital and $5 million for a land purchase, reflecting confidence in demand visibility. With five more hospitals set to open this year and continued private room conversions, capacity expansion is prioritized over acquisitions or adjacencies.
2. Clinical Quality as Differentiator
Best-in-class clinical protocols and strong quality outcomes underpin EHC’s referral relationships and JV model. Discharge to community rates (84.8%) and net promoter scores consistently outpace industry averages, supporting preferred partner status with acute care hospitals and payers. The company’s data-driven approach to functional outcomes is a key selling point for both referral sources and physicians.
3. AI and Predictive Analytics for Efficiency
AI adoption is focused on reducing administrative burden and improving care consistency. Partnerships with Palantir and Oracle are enabling faster, more accurate patient evaluations and documentation, freeing up staff time and improving job satisfaction. Predictive models for fall risk and acute care transfers have reduced incidents by 30% and 24% respectively since 2020, demonstrating tangible quality and efficiency gains.
4. Labor Stabilization and Retention Initiatives
Centralized talent acquisition and career ladders are helping EHC maintain net hiring momentum and reduce turnover, especially among nurses. Turnover has returned to pre-pandemic levels (21%), and targeted workflow improvements are further supporting retention. Contract labor use remains low and stable, mitigating wage inflation risk.
5. Disciplined Capital Allocation
Management is balancing capacity expansion with shareholder returns. With leverage at 2x and robust free cash flow, EHC is increasing its dividend and stepping up share repurchases. M&A remains a secondary consideration, with De Novo and bed expansions offering superior returns versus IRF portfolio acquisitions or service line adjacencies.
Key Considerations
Encompass Health’s Q2 results reflect a business leaning into secular demand and operational discipline, but cost inflation and capital deployment choices remain pivotal.
Key Considerations:
- Population Tailwind: The 65+ population is growing at a 3% CAGR, with the 75+ segment up 4%, fueling long-term demand for inpatient rehab.
- Capacity Constraints: Licensed IRF bed supply has barely increased, making EHC’s expansion strategy critical to capturing market share.
- Benefits Cost Volatility: High-dollar medical claims are a persistent risk to margin, though management expects moderation in H2.
- Occupancy and Utilization: Mature private room facilities can operate in the mid to high 90% occupancy, supporting further expansion as existing sites fill up.
- AI-Driven Productivity: Efficiency gains in documentation and risk management are beginning to show measurable impact on both cost and quality metrics.
Risks
Benefits expense inflation remains a key risk, with high-dollar claims driving double-digit cost increases that may not fully abate in the near term. Labor market tightness could reemerge, particularly for specialized clinicians and therapists, despite current stabilization. Regulatory changes, especially around quality measurement and reimbursement, could introduce volatility. Tariff and construction cost inflation are being monitored, though not yet impacting capex materially. Execution risk around rapid capacity expansion and integration of new sites also warrants attention.
Forward Outlook
For Q3 2025, Encompass Health guided to:
- Continued discharge growth, supported by new hospital and bed openings
- Moderating benefits expense growth as 2024 cost spikes are lapped
For full-year 2025, management raised guidance:
- Net operating revenue of $5.88 to $5.98 billion
- Adjusted EBITDA of $1.22 to $1.25 billion
- Adjusted EPS of $5.12 to $5.34
- Adjusted free cash flow of $705 to $795 million
Management cited strong demand visibility, occupancy-driven expansion, and tax benefits as drivers of the upward revision, while flagging that pre-opening costs and new capacity will weigh on near-term margins but support future growth.
- Five additional hospitals and multiple bed expansions slated for H2
- Ongoing focus on hiring and retention to support growth
Takeaways
Encompass Health is capitalizing on secular demand and occupancy gains, but cost management and disciplined capital deployment remain critical to sustaining outperformance.
- Capacity Expansion Is the Core Growth Engine: New hospitals and bed additions are the primary lever for capturing underserved demand, with organic growth prioritized over M&A.
- Quality and Technology Differentiate the Platform: Superior clinical outcomes and AI-driven efficiency are deepening referral relationships and supporting margin stability.
- Cost Pressures Require Vigilance: Benefits and labor inflation are persistent risks; investors should monitor expense trends and the impact of new capacity on utilization and profitability.
Conclusion
Encompass Health’s Q2 underscores the power of occupancy-driven growth and disciplined execution in a structurally advantaged market. The company’s ability to balance aggressive expansion with operational rigor and quality leadership will define its long-term value creation as demographic and payer tailwinds persist.
Industry Read-Through
The inpatient rehabilitation sector is experiencing a demand surge as the US population ages and the supply of licensed beds remains tight. Operators with scale, clinical quality differentiation, and strong referral networks are positioned to gain share as acute care partners seek reliable post-acute solutions. EHC’s focus on organic growth and AI-enabled productivity offers a template for margin defense amid labor and benefit inflation. Investors in post-acute and specialty care should watch for continued capacity constraints, payer mix shifts, and regulatory developments around quality measurement as key industry drivers.